跳至主要内容
临床试验/CTRI/2018/10/016196
CTRI/2018/10/016196已完成3 期

Efficacy of Individualized Homoeopathic Medicines in the Treatment of Post-Stroke Hemiparesis: An Open, Randomized, Placebo-Controlled Clinical Trial

ational Institute Of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Cases suffering from Post-stroke Hemiparesis consistently for more than 3 months
  • 2. Both male and female patients
  • 3. Age 35- 70 years
  • 4. Ability to read English and/or Bengali
  • 5. Capability and willingness to give informed consent and to comply with the study protocol

排除标准

  • 1. Patients not willing to participate in the study and denying consent
  • 2. Hemiparesis due to causes other than stroke
  • 3. Patients with psychiatric disorders
  • 4. Pregnant or lactating women
  • 5. Self-reported immune-compromised state
  • 6. Substance abuse and/or dependence
  • 7. Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure
  • 8. Cases already undergoing homeopathic treatment for any chronic disease within eight weeks prior to enrolment

研究者

发起方
ational Institute Of Homoeopathy

相似试验